Opendata, web and dolomites

NANOFLOWSIZER

Developing a disruptive and revolutionary tool for real time inline nanoparticle size measurement, for superior quality control and process efficiency.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NANOFLOWSIZER project word cloud

Explore the words cloud of the NANOFLOWSIZER project. It provides you a very rough idea of what is the project "NANOFLOWSIZER" about.

goods    nanoflowsizer    employees    pfizer    worth    interferometry    manufacturers    risk    size    former    defective    continuous    exposes    scattering    determinant    batches    pharmaceutical    industries    nano    coherence    2m    rejection    efficacy    2020    speed    safety    food    tool    costing    measuring    sampling    merck    impractical    nanotechnology    lsp    flowing    academia    founded    quality    dls    np       date    tools    inflow    poor    event    billion    msd    rate    drawbacks    inprocess    99    2017    attracted    revenue    companies    integrity    prototype    drugs    stage    optimisation    suspensions    industrial    chemical    rejected    dynamic    light    50    samples    regulator    remote    eliminating    ps    5m    market    particle    nps    consumers    offline    beverage    global    compromises    teva    turbid    ge    time    requiring    psd    65    nfs    valuable    big    discarded    instrument    netherlands    gives    274m    skilled    batch    inline   

Project "NANOFLOWSIZER" data sheet

The following table provides information about the project.

Coordinator
INPROCESS-LSP BV 

Organization address
address: KLOOSTERSTRAAT 9
city: OSS
postcode: 5349 AB
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INPROCESS-LSP BV NL (OSS) coordinator 50˙000.00

Map

 Project objective

Nanotechnology is rapidly growing in the pharmaceutical, chemical, food & beverage industries. The global market for Nano-based goods will reach €65 Billion by 2020. A regulator of growth is quality control of Nano particle (NP) size (PS) and size distribution (PSD). The size of NPs is a determinant of their properties e.g. a change in the NP size affects the efficacy and safety of drugs. Thus, the market for NP size measurement tools is rapidly growing and in 2017 was worth €274M. To date, there is no instrument able to measure NP PS and PSD inflow. Size measurement is done offline using Dynamic Light scattering (DLS) - requiring product sampling which is often impractical as it compromises the integrity of samples. DLS systems cannot measure NP size in turbid flowing suspensions and therefore, gives measurements after batches have been produced. Defective batches are discarded costing manufacturers €0.2-2M per event with ≥50% of all batches rejected. Poor quality control exposes consumers to increased risk. There is a need for NP size measurement tools able to measure NP suspensions inflow. InProcess-LSP was founded by highly skilled former employees of MSD/Merck in Netherlands. InProcess-LSP has developed the Nanoflowsizer (NFS) a novel instrument capable of real time, inline measurement of NP PS and PSD using Low Coherence Interferometry. The NFS will provide a remote measuring tool for continuous quality control. It will achieve a 0% batch rejection rate increasing quality processing speed by 99% eliminating the drawbacks of sampling. Manufacturers will have greater control and valuable insight for process optimisation. The advanced stage of development the prototype has attracted big pharmaceutical companies including Teva and Pfizer who are our industrial partners. Target users also include NP-based manufacturers in the food and beverage and in academia. The NFS project will achieve a revenue of €4.5M by 2020 and 20 new employees.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANOFLOWSIZER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NANOFLOWSIZER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More  

Skye (2018)

Redefining Drone Safety and Autonomous Operation for Indoor Commercial Applications

Read More